OBJECTIVE: To determine whether factors related to body weight might in¯uence the cholesterol lowering response to diet. DESIGN: Run-in diet followed by crossover to low fat diets; average response is reported. SUBJECTS: Sixty-three subjects (30 men and 33 women) with moderately elevated plasma cholesterol levels. MEASUREMENTS: Lipid and anthropometric measurements. Data were analyzed as a repeated measures analysis of variance with lipid lowering response in all combined cholesterol lowering diets compared to baseline. RESULTS: LDL cholesterol lowering was signi®cantly affected by BMI in women (P 0.01) but not in men (P 0.54). There was also a weak effect of waist-hip (W/H) ratio on response (P 0.127) in women, with the lower responders having a higher W/H ratio but there was no effect of W/H ratio in men (P 0.86). CONCLUSION: These results suggest that overweight women with elevated plasma cholesterol may be less responsive to reducing their cholesterol levels with diet.
Introduction
A number of equations have been formulated over the years to predict cholesterol lowering response to changes in dietary fat and cholesterol. 1±4 The implication of these reports is that changes in cholesterol can be predicted, however, the variation in individual response can be quite large. 5 The factors that determine dietary response are not well understood, despite an increasing number of studies examining this issue. Many recent studies have focused on genetic differences to explain the variation in dietary response. A hypo-and hyperresponder phenomenon is well documented in animal studies, 6, 7 but no de®nitive genetic determinants have been identi®ed in these models to date. In ®ndings similar to those from animal studies, Katan et al 8, 9 reported that human subjects who are responsive to one type of dietary manipulation, such as a lowcholesterol diet, are more likely to be responsive to other dietary modi®cations to lower cholesterol levels. Several genetic determinants have been shown to modify dietary response, including polymorphisms of apolipoprotein (apo)B, apoE and apoA-IV.
10±13
Although these studies suggest that genetics plays a role in the response to cholesterol lowering diets, it is likely that dietary response is affected by a combination of both genetic and environmental factors.
One environmental factor suggested to affect both baseline cholesterol levels and dietary response is obesity.
14±16 Several large population studies have shown that obesity is associated with increased cholesterol concentrations, 17±20 although the differences between lean and obese subjects may be greater at younger ages than in middle-age. 21, 22 Diet intervention studies have shown an association between reduced LDL cholesterol lowering and obesity. 23, 24 In addition to the issue of weight is the factor of body fat distribution. An android body fat distribution, characterized by a greater waist-hip (W/H) ratio, is associated with an increased risk for non-insulin dependent diabetes mellitus (NIDDM) and coronary heart disease. 25, 26 There can be a strong relation between W/H ratio and LDL cholesterol levels even when BMI does not correlate with total or LDL cholesterol concentration. 27±34 Several studies have shown an increased W/H ratio to be associated with an increased risk for coronary heart disease, when BMI was not.
35±39 Thus, both obesity and a central fat distribution can effect LDL concentrations. Therefore, we examined the associations of BMI and body fat distribution with response to a lipid-lowering diet in a large diet study in men and women who had mild to moderate hypercholesterolemia.
Methods

Screening of subjects
A total of 365 volunteers were screened for moderate hypercholesterolemia. Participants gave a complete medical history and underwent a physical examination that included an electrocardiogram and blood and urine chemistries. LDL and triglyceride concentrations were determined by averaging two separate measurements.
Anthropometric measurements included height, weight, and percent body fat as measured by bioelectric impedance (RJL Equipment Co., Detroit, MI). Waist circumference was measured midway between the lateral lower rib and the iliac crest with subjects in the supine position. Hip circumference was measured with participants standing, at the level of the trochanters and through the pubic symphysis at the maximum protrusion of the gluteal muscles.
Candidates were assessed for predicted compliance by completion of a diet history and a 3 d food record. Each subject's caloric requirement was estimated from the food record. Subjects were asked not to change their smoking habits or their patterns of physical activity. Menstrual history was obtained from premenopausal women; post menopausal estrogen use was allowed if dosage was stable.
Of those screened, 63 eligible subjects between 20 and 55 y of age met the eligibility criteria, which consisted of LDL cholesterol between 130 and 190 mg/dl (3.37±4.91 mmol/L), triglycerides`350 mg/dl (3.95 mmol/L). Exclusion criteria, detailed elsewhere, 40 included use of dietary supplements, history of coronary heart disease or of eating disorders. The study was conducted in two cohorts due to the large number of meals to be prepared.
Diet
For a six-week period, subjects consumed a baseline diet that was designed to be similar to a typical American diet, namely that containing 37% total fat (with a distribution of 15% saturated, 19% monounsaturated, and 3% polyunsaturated fat (Table 1) . After the baseline period, subjects were randomized into four groups that consumed all four low-fat diets in a prescribed order, each for a six-week period. The four diets varied only in their proportions of mono-and polyunsaturated fat. All diets had a total fat content similar to that recommended by the National Cholesterol Education Program (NCEP) Adult Treatment Panel for a Step 1 diet (30%), with saturated fat limited to 10% of total calories. 41, 42 Other components of the diet that might have in¯uenced plasma lipoproteins were held constant on all diets; namely that average cholesterol intake was maintained at 150 mg/1000 kcal and ®ber at 8 g/1000 kcal (2±3 g soluble ®ber). The diets were formulated with commonly used foods, and all food, calorie-containing beverages, and snacks were supplied to the study subjects. Four menus were developed for each diet, and from these two 7 d cycles of recipes were prepared. Subjects were weighed frequently during the baseline diet, and twice a week for the remainder of the study. Compliance with the prescribed intake of dietary fat was assessed by self reporting in daily logs that were reviewed by the dietitians during twice-weekly visits. Unannounced 24 h recalls were also performed. All study participants and personnel, except the food preparation supervisor and one member of the statistical staff, were blinded to the diet assignments.
Blood sampling and measurement
Duplicate fasting blood samples were obtained on two separate days at the end of each six-week diet period. Blood was collected in tubes containing K 2 EDTA (1.5 mg/ml) and plasma was separated immediately by centrifugation (1700 6 g, 10 min, 4 C). Triglycerides and cholesterol were measured enzymatically as described by Wahlefeld 43 and Allain 44 on a Hitachi 717 automated chemistry analyzer (Hitachi, Tokyo, Japan). VLDL (d`1.006 g/ml) was isolated by ultracentrifugation (39 000 rpm, 16 h, 20 C) in a Beckman 50.4 Ti rotor (Beckman, Fullerton, CA) and cholesterol was measured in VLDL and the infranatant fraction (d b 1.006 g/ml). HDL cholesterol was measured after precipitation of apoB containing lipoproteins with heparin and manganese chloride. LDL cholesterol was calculated by subtracting HDL cholesterol from total cholesterol in the fraction d b 1.006 g/ml. Values for the duplicate measurements of the lipoproteins were averaged and reported. All blood analyses were performed by the Penn Medical Laboratory of the Medlantic Research Institute, a participant in the Centers for Disease Control and Prevention/National Heart, Lung, and Blood Institute (CDC-NHLBI) Lipid Standardization Program. The coef®cients of variation in control plasma pools were 1.6±2.4% for triglyceride, 0.6±0.9% for total cholesterol, and 1.5±2.9% for HDL cholesterol.
Data analysis
Both the dietary response on the diets and an average of the dietary response across all four low-fat diets was compared with cholesterol values from the end of the baseline diet period. The diet averaging was performed to control for differences in dietary effects, the primary research question. After the results were tested for normality, the data were examined by gender and the covariates, BMI and W/H ratio were tested in a repeated measures analysis of variance. Percent body fat was highly correlated with BMI in both men and women (r 0.46 and 0.52, respectively) and therefore, both variables could not be examined in the same model. Pearson's correlation analysis was also determined.
Results
The characteristics of the study participants, including their baseline lipids, are shown in Table 2 . Men and women were equally represented, and the subjects, recruited to be moderately hypercholesterolemic, had total cholesterol concentrations averaging 236 mg/dl (6.10 mmol/L) and LDL cholesterol averaging 160 mg/dl (4.14 mmol/L). Average baseline total and LDL cholesterol concentrations were similar in men and women as were the ranges. The average BMI was similar in both men and women, with men being slightly heavier than women, 27.4 AE 3.4 vs 25.5 AE 3.9 kg/m 2 ( Table 2 ). The range for BMI was also similar for both genders (21±35 for men and 20±35 kg/m 2 for women). Percent body fat was higher for women than men, 30.7 AE 8.1± 21.5 AE 7.7%. W/H ratios ranged from 0.67±0.94 for women compared to 0.85±1.01 for men. Correlations between BMI, W/H ratio, and % body fat are shown in Table 3 . BMI was signi®cantly correlated with percent body fat in both men and women. In women, BMI was also signi®cantly correlated with waist to hip ratio. There was no relation between baseline total or LDL cholesterol with BMI in men (r 70.04 and r 70.01, respectively) or in women (r 70.14 and r 0.17) (data not shown).
The changes from baseline or total cholesterol, LDL cholesterol, HDL cholesterol, and total triglycerides for each of the four low-fat diets have been reported previously. 40 Overall, women had a slightly greater response to the diets, with an average LDL cholesterol decline of 9.5 AE 16.2 mg/dl (0.25 AE 0.42 mmol/l), compared to 6.2 AE 15.1 mg/dl (0.16 AE 0.39 mmol/l) for men, but this difference was not statistically signi®cant.
The decrease in LDL cholesterol levels from baseline to the average of the low fat diets was related to BMI in women, r 0.35, P`0.01 (Figure 1a ). There was, however, no effect of BMI on LDL response in men (P 0.50) (Figure 1b) . The effects of BMI on total and LDL cholesterol change were signi®cant (P 0.03 for total cholesterol; P 0.01 for LDL) in women but not in men. Examining the data for women consuming diet no. 3, a diet with a moderately high polyunsaturated fat content, tertiles of BMI showed decreased LDL cholesterol lowering by increased BMI (Figure 2 ) There was no relation between BMI and changes in triglyceride or changes in either gender (Table 4) . 
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The relation between percent body fat and LDL cholesterol response for men and women is shown in Figure 3 . The combined data, allowing for an increased range of percent body fat, show that body fat does not explain the difference between genders in the effect of BMI on LDL lowering.
When subjects were divided into low and high W/H ratio and compared, LDL response was greater in women with the low ratio (Figure 4 ) but, the relation between W/H and cholesterol lowering did not reach signi®cance for either gender.
Discussion
The results of this study suggest that the LDL cholesterol response to a cholesterol lowering diet appears to be reduced in overweight women, but not in men. The gender difference in the effect of BMI could not be attributed to differences in baseline values since initial cholesterol concentrations and BMI were similar in men and women. Thus, increasing weight in women seems to impair their response to a cholesterol-lowering diet.
A few other studies have also suggested that obese subjects appeared to be less responsive to diet modi®cation. 23, 24 Bronsgeest-Schoute et al 23 observed that when eggs were removed from the diets of subjects who normally consumed eggs, the obese subjects experienced no change in cholesterol levels. A similar observation was made in a small feeding study of hypercholesterolemic women, 24 in which only the leanest women showed a signi®cant decrease in LDL cholesterol levels on an American Heart Association (AHA) Phase 3 diet. Finally, results from the Chicago Western Electric Study showed that a change in dietary cholesterol intake was correlated with a change in serum cholesterol in lean but not obese males. 20 On the other hand, Clifton et al failed to ®nd an effect of BMI on LDL response 45 however these subjects were not selected to have elevated cholesterol levels. Both BMI and WHR affected the HDL response to diet with those with a higher BMI and Obesity and cholesterol lowering in women JS Hannah et al waist circumference having less change in HDL. These results, taken in total, suggest that obese subjects may be more resistant to dietary manipulations to lower plasma cholesterol. This is the ®rst study, however, to suggest that the effect of BMI is more pronounced in women than in men. Participants' self-reports of compliance revealed no difference between lean and obese subjects or between men and women. 40 The VLDL fatty acid content of 18:2 also correlated with dietary treatment, P`0.0001 (data not shown). Therefore, poor dietary compliance did not appear to explain differences in dietary response.
A possible explanation for the effect of BMI on cholesterol-lowering in women may be their higher percentage of body fat. Adipose tissue produces and stores cholesterol; 46 thus, an individual with a greater fat depot would likely produce more cholesterol, thereby maintaining a high plasma cholesterol concentration despite dietary modi®cation. Additionally, the greater adipose tissue mass in women could contribute more endogenous cholesterol production to the total pool. In this study, however, there was considerable overlap in percent body fat between men and women; thus, differences in body fat did not appear to fully explain the gender effect. Body weight is known to be strongly correlated with cholesterol production, 47 yet it is not known whether the rate of cholesterol synthesis differs between men and women.
Body fat distribution may also confer certain metabolic characteristics. 29, 30 An android pattern of fat distribution, characterized by a high W/H ratio, is considered to be a risk factor for the development of NIDDM and cardiovascular disease. The present results suggest that the LDL response to cholesterol lowering diets in women may be reduced in those with a high W/H ratio. While the effect of increasing W/H ratio on response in women was small, it may well be an additional factor that increases the risk of cardiovascular disease. W/H ratios in men in this study were in a narrow range; thus, there was diminished power to assess the relation between W/H and LDL response in men. It is possible that if central fat is the factor inhibiting LDL response, then a relation between BMI and LDL lowering might be observed in a group of men selected over a wide range of W/H ratio.
Conclusions
The results of this present study, coupled with those of other reports, suggest that being overweight confers a resistance to cholesterol lowering in women and that a central body fat distribution may also play a role in attenuating LDL response to diet. Thus, the general recommendations to reduce dietary fat may not produce the expected LDL cholesterol lowering in overweight women. Data from the National Health And Nutrition Examination Survey (NHANES III), conducted between 1988 and 1991, showed that the percentage of overweight subjects in the United States has increased 8% since the 1976±1980 survey. 48 Currently, it is estimated that 33.4% of adult Americans are overweight, and that women account for a higher percentage than men (34.0 vs 32.1%, respectively). Furthermore, overweight Americans represent a segment of the population that is more likely to require cholesterol-lowering therapy because cholesterol levels are more often elevated in these subjects. Thus, current diet recommendations to reduce plasma cholesterol levels may be ineffective for a large percent of women in this country whose numbers are likely to increase. These data suggest that overweight women may need to make additional lifestyle changes, such as weight loss or increased exercise, to achieve cholesterol lowering when following NCEP dietary guidelines.
